Find out the latest with BOPA, Oncology, and upcoming events
Dear BOPA members In cancer care, little is known about the impact of specific brands of oral SACT medication or how healthcare professionals respond and process brand switches of oral…
Dear Member, Regarding the earlier communication for registering to become a creator/reviewer of mock prescriptions: This process has been amended and creation/review is open to free associates and above, as…
The Independent Sector Cancer Network (ISCN) is a strategic quality governance and safety group which aims to improve independard sector cancer provision though effective collaboration and sharing of best practice across the…
Dear BOPA Members, The EDQM (the European Directorate for the Quality of Medicines&Healthcare of the Council of Europe) is conducting a survey following a study from national monitoring activities, which…
From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancers New Publication by BOPA Member and AI Specialist Advisory Group (SAG)…
Dear All, I am happy to inform you that the MPN consent forms have been reviewed and updated. Furthermore, a new consent form has been added form for Nivolumab with…
The next episode of Let’s Talk About SACT is Let’s talk about Acute Oncology. In this episode we are joined by Caroline Wilson and Alison Taylor. We discuss what acute…
Dear Member, It has been 12 months since the launch of the “BOPA SACT Verification Passport”. In order to optimise user experience of the Passport, we need to have new…
Dear colleagues, Hypercalcaemia of malignancy is the commonest metabolic complication in cancer patients and there is a lack of evidence in this area, leading to potential variation in clinical practice.…
Dear Members The revised BOPA vision was presented during the AGM at the 2024 BOPA conference in Birmingham. (The AGM slides can be found here) The revised vision is a…
Dear member, As of the beginning of this month, we have 139 registered sites and 1,600 users subscribed to the SACT verification passport. This is a fabulous uptake and…
A message from the BOPA Immunotherapy SAG: It brings us great pleasure to inform you that the Research & Analysis pillar of the BOPA Immunotherapy SAG has successfully submitted abstract…
